| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.9B | $24.4B | $24.4B | $21.7B | $20.6B | $18.5B | $17.1B | $16.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.7B | $4.5B | $2.7B | $1.8B | $1.9B | $1.8B | $-10.1B | $-9.7B |
| Net Income | $2.7B | $2.5B | $2.3B | $1.8B | $-0.1B | $-1.3B | $-7.6B | $-6.8B |
| EPS (Basic) | $1.18 | $1.16 | $1.09 | $0.91 | $-0.05 | $-1.05 | $-14.50 | $-13.25 |
| EPS (Diluted) | $1.18 | $1.15 | $1.05 | $0.84 | $-0.05 | $-1.05 | $-14.50 | $-13.25 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $141.6B | $133.7B | $125.7B | $118.6B | $103.3B | $97.9B | $85.2B | $77.0B |
| Current Assets | $15.8B | $17.2B | $14.4B | $12.8B | $11.1B | $9.6B | $10.2B | $9.2B |
| Cash & Equivalents | $0.7B | $0.9B | $0.6B | $0.7B | $0.3B | $0.5B | $1.6B | $1.7B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $16.3B | $16.3B | $17.3B | $15.8B | $17.4B | $13.6B | $7.6B | $41.7B |
| Stockholders' Equity | $32.5B | $30.1B | $25.0B | $22.8B | $21.0B | $21.0B | $5.1B | $12.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.7B | $8.0B | $4.7B | $3.7B | $2.3B | $-19.1B | $4.8B | $4.8B |
| Investing Cash Flow | $-12.3B | $-11.4B | $-9.2B | $-10.2B | $-6.9B | $-7.7B | $-6.4B | $-6.6B |
| Capital Expenditures | $11.8B | $10.4B | $9.7B | $9.6B | $7.7B | $7.7B | $6.3B | $6.5B |
| Financing Cash Flow | $3.4B | $3.6B | $4.4B | $7.1B | $4.3B | $25.9B | $1.5B | $3.0B |